(5R,6S)-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-2-naphthalenol (2S,3S)-2,3-dihydroxybutanedioate

CAS: 190791-29-8

Ref. 3D-FT75956

Produktinformation

• Name: (5R,6S)-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-2-naphthalenol (2S,3S)-2,3-dihydroxybutanedioate
• Synonyme: Lasofoxifene tartrate, (-)-cis-5,6,7,8-Tetrahydro-6-phenyl-5-(p-(2-(1-pyrrolidinyl)ethoxy)phenyl)-2-naphthol D-tartrate (1:1) (salt), (5R,6S)-6-phenyl-5-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol 2,3-dihydroxybutanedioate (salt), 2-Naphthalenol, 5,6,7,8-tetrahydro-6-phenyl-5-(4-(2-(1-pyrrolidinyl)ethoxy)phenyl)-, (5R,6S)-, (2S,3S)-2,3-dihydroxybutanedioate (1:1) (salt), 2-Naphthalenol, 5,6,7,8-tetrahydro-6-phenyl-5-(4-(2-(1-pyrrolidinyl)ethoxy)phenyl)-, (5R-cis)-, (S-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt), 2-Naphthalenol, 5,6,7,8-tetrahydro-6-phenyl-5-(4-(2-(1-pyrrolidinyl)ethoxy)phenyl)-, cis-(-)-, (S-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt), 2-Naphthalenol, 5,6,7,8-tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-, (5R,6S)-, (2S,3S)-2,3-dihydroxybutanedioate (1:1), Cb 336156Eb, Cp 336156, Fablyn, Oporia, Unii-85X09V2Gso

Beschreibung

(5R,6S)-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-2-naphthalenol (2S,3S)-2,3-dihydroxybutanedioate is a regulatory agent that targets the vaginal tissue. It has been shown to have a safety profile and is used for the treatment of vaginal atrophy. This drug has anti-inflammatory properties and may be useful in the treatment of cancer. The compound is an orally active agent that can be synthesized in an asymmetric fashion. It has been shown to stimulate epidermal growth factor production in vitro and may be useful for treating skin disorders such as psoriasis.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 563.64 g/mol
• Formel: C₂₈H₃₁NO₂·C₄H₆O₆
• Reinheit: Min. 95%